Cearvol Wave vs MDHearing Volt

The Cearvol Wave is a budget-priced OTC hearing aid with a visible in-ear style, earning a B grade with a SoundScore of 3.9/5 in our lab testing. At $397, it ranks #22 among 65 OTC hearing aids tested, placing it in the top 32% of its category. This device demonstrates notable strengths in music streaming, scoring 4.1/5—a strong result that sits 2.18 points above the OTC category average. Speech performance is solid in quiet environments at 3.1/5, measuring 0.36 points above average. Speech in noise scores 2.0/5, which is above the category average by 0.56 points, though this remains a mixed result in absolute terms. The Cearvol Wave shows some trade-offs in other areas. Own-voice comfort scores 2.1/5, falling 0.41 points below the category average—a consideration for those sensitive to how their own voice sounds while wearing hearing aids. Feedback handling measures 3.8/5, which is solid in absolute terms, though it sits 0.74 points below the typically strong OTC category average for this metric. The Cearvol Wave is best suited for budget-conscious consumers who prioritize music streaming quality and want solid speech clarity in quieter settings. Those who frequently encounter noisy environments or are particularly sensitive to own-voice quality may want to consider alternatives.

The MDHearing Volt is a budget-priced prescription hearing aid released in 2020, earning a B grade with a SoundScore of 3.0/5 in our lab testing. At $397, it sits in the lowest price tier for prescription devices, ranking #34 of 39 in its category. In our testing, the Volt showed a mixed performance profile with one standout strength: feedback handling scored an excellent 5.0/5, which is 0.28 points above the category average. This means users can expect minimal whistling or squealing during typical wear. However, speech performance was limited, with speech in quiet scoring 1.8/5 (1.65 points below average) and speech in noise at 1.0/5 (1.11 points below average). Own voice comfort was mixed at 2.6/5, roughly matching the category average. Music streaming capability was not functional in our testing, scoring 0.0/5—a significant limitation for users who want to stream audio from their phone. This is 2.76 points below the prescription hearing aid category average. The Volt may appeal to budget-conscious consumers who prioritize basic amplification and feedback-free wear over advanced speech enhancement or streaming features. Those seeking stronger speech performance in the same price range may want to consider alternatives like the RxEars Rxi, which scored 4.07/5 in our testing. The Volt's rechargeable battery and behind-the-ear design offer practical convenience, but its core sound performance reflects its entry-level positioning.